查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1617716

止血剂市场：按类型、配方和应用分类 - 2025-2030 年全球预测

Hemostats Market by Type (Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年止血剂市值为32.3亿美元，预计到2024年将达到34.2亿美元，复合年增长率为5.65%，到2030年将达到47.5亿美元。

止血剂的范围和定义是指在手术或创伤环境中透过促进血液凝固来止血的医疗设备和物质。止血剂在择期和紧急外科手术中对于改善患者的復原时间和结果至关重要，特别是在心血管手术、创伤治疗和某些类型的器官移植中。最终用途包括医院、门诊手术中心、专科诊所以及全球军事和创伤中心日益增长的需求。根据市场洞察，止血剂市场主要是由外科手术的增加以及医疗基础设施的进步（尤其是在新兴国家）推动的。开发生物分解性降解止血剂和适用于微创手术的产品等创新为公司扩大产品范围提供了潜在机会。关键的成长要素包括人口老化、需要手术介入的慢性疾病的增加以及发展中地区医疗保健支出的增加。然而，仍然存在巨大的限制，例如严格的监管要求、潜在的副作用以及先进止血产品的高价格，这可能会阻碍市场的成长。此外，来自替代创伤护理和止血产品的竞争可能会对市场扩张产生不利影响。创新的最佳领域包括开发生物相容性更好、更快起效且副作用更少的下一代止血剂，以及投资研究探索止血剂在新外科手术中的使用。此外，创建永续且具有成本效益的解决方案可以扩大资源匮乏环境中的访问范围并提供开拓的市场潜力。市场竞争激烈，保持领先需要与研究机构建立策略联盟和合作。总之，虽然机会比比皆是，但企业必须驾驭监管环境，投资研发以应对挑战，并有效抓住成长机会。

主要市场统计
基准年[2023] 32.3亿美元
预测年份 [2024] 34.2亿美元
预测年份 [2030] 47.5亿美元
复合年增长率（%） 5.65%

市场动态：揭示快速发展的止血剂市场的关键市场洞察

供需的动态交互作用正在改变止血剂市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 慢性病的流行增加了手术介入的需要
    • 人们对微创手术的兴趣日益浓厚
  • 市场限制因素
    • 产品召回增加
  • 市场机会
    • 基于生物聚合物的一次性止血剂的兴起
    • 透过奈米技术的整合，实现更有效率、更有针对性的止血剂
  • 市场问题
    • 使用止血工具和试剂相关的感染和交叉污染的风险

波特的五力：驾驭止血剂市场的策略工具

波特的五力架构是了解止血剂市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解止血剂市场的外部影响

外部宏观环境因素对止血剂市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解止血剂市场竞争格局

止血剂市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵：止血剂市场供应商绩效评估

FPNV定位矩阵是评估止血器市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製止血剂市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，止血剂市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病的流行增加了手术介入的需要
      • 微创手术日益增长
    • 抑制因素
      • 产品回收数量增加
    • 机会
      • 基于生物聚合物的一次性止血剂的兴起
      • 奈米技术的整合创造了更有效率、更有针对性的止血剂
    • 任务
      • 使用止血工具和试剂相关的感染和交叉污染的风险
  • 市场区隔分析
    • 类型：由于减少出血的效果改善，扩大了合併止血剂的使用
    • 配方：粉状止血剂在手术介入期间控制和预防出血的成长潜力
    • 应用：止血剂在心血管手术中预防失血、确保手术成功的重要作用
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章止血剂市场：按类型

  • 介绍
  • 胶原蛋白止血剂
  • 混合止血剂
  • 明胶止血剂
  • 氧化再生纤维素系止血剂
  • 凝血酶止血剂

第七章止血剂市场：依配方

  • 介绍
  • 基质和凝胶
  • 粉末
  • 座椅和垫片
  • 海绵

第八章止血剂市场：依应用分类

  • 介绍
  • 心血管外科
  • 一般外科
  • 妇科手术
  • 神经外科
  • 整形外科
  • 重组手术

第九章美洲止血剂市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太止血剂市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲止血剂市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Teleflex 获得 FDA核准在心臟手术中扩大 QuikClot Control+ 止血装置的使用
    • 百特推出可吸收止血粉“PERCLOT”
    • Artivion 的 PerClot 获得 FDA核准并开始转移到 Baxter
    • Olympus Europa SE & Co. KG 扩大与 Endoclot 的合作关係，推出止血剂
    • Darling Ingredients 完成对巴西明胶和胶原蛋白製造商 Gelnex 的收购
    • 用于减少严重手术出血的几丁聚醣止血剂已获得 FDA 批准
    • Advamedica Inc 宣布 Ax-Surgi 手术止血器获得 FDA 批准
    • Medcura 的 LifeGel 可吸收手术止血材料获得突破性器械称号
    • 美敦力公司的 Nexpasdar 内视镜止血系统获得美国FDA 批准
    • Hemostasis LLC 完成对 Fiagon Medical Technologies 的收购
  • 战略分析和建议

公司名单

  • AR Medicom, Inc.
  • ACTEON Group
  • Advamedica Inc.
  • Advanced Medical Solutions Group PLC
  • Advin Health Care
  • Aegis Lifesciences Private Limited
  • Argon Medical Devices
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Betatech Medical
  • Convatec Group PLC
  • Cook Group Incorporated
  • Cortis Medtech Pvt Ltd
  • Cotran Corporation
  • Dolphin Sutures by Futura Surgicare Pvt. Ltd.
  • Dynarex Corporation
  • Gelita AG
  • Hangzhou Singclean Medical Products Co.,Ltd.
  • Healthium Medtech Ltd
  • Hemostasis, LLC
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Medcura, Inc.
  • Medline Industries, LP
  • Medprin BIoTech GmbH
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • Olympus Corporation
  • Pfizer Inc.
  • Rousselot BV by Darling Ingredients International Holding BV
  • Royal DSM
  • Shilpa Medicare Limited
  • Stapleline Medizintechnik GmbH
  • Stryker Corporation
  • SYMATESE
  • Teleflex Incorporated
  • Terumo Corporation
  • Zhejiang Perfectseal New Material Technology Co., Ltd.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-961BA04A2E36

The Hemostats Market was valued at USD 3.23 billion in 2023, expected to reach USD 3.42 billion in 2024, and is projected to grow at a CAGR of 5.65%, to USD 4.75 billion by 2030.

The scope and definition of hemostats pertain to medical devices or substances utilized to arrest bleeding in surgical and trauma scenarios by promoting the coagulation of blood. Hemostats are essential in both elective and emergency surgical procedures to enhance patient recovery times and outcomes, particularly in cardiovascular surgery, trauma care, and certain types of organ transplants. The end-use scope extends across hospitals, ambulatory surgical centers, and specialty clinics, with an increasing demand observed in military and trauma centers globally. Market insights reveal that the hemostats market is predominantly driven by a rise in surgical procedures, coupled with advancements in healthcare infrastructure, particularly in emerging economies. Technological innovations, such as the development of biodegradable hemostats and products suited for minimally invasive procedures, offer potential opportunities for businesses to expand their offerings. Key growth factors include an aging population, a rise in chronic conditions that necessitate surgical intervention, and increased healthcare spending across developing regions. However, substantial limitations persist, including stringent regulatory requirements, potential side effects, and the high cost of advanced hemostatic products, which may hinder market growth. Additionally, competition from alternative wound care and blood styptic products can negatively impact market expansion. The best areas for innovation include the development of next-generation hemostats with enhanced biocompatibility, faster action, and fewer adverse effects, as well as investment in research exploring the use of hemostats in novel surgical techniques. Additionally, creating sustainable, cost-effective solutions can broaden access in low-resource settings, providing untapped market potential. The competitive nature of the market demands strategic partnerships and collaborations with research institutions to stay ahead. In conclusion, while promising opportunities abound, companies must navigate regulatory landscapes and invest in R&D to address challenges and seize growth prospects effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 3.23 billion
Estimated Year [2024] USD 3.42 billion
Forecast Year [2030] USD 4.75 billion
CAGR (%) 5.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hemostats Market

The Hemostats Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic disorders with increasing need for surgical interventions
    • Growing inclination toward minimally invasive surgeries
  • Market Restraints
    • Rising incidences of product recalls
  • Market Opportunities
    • Rise of biopolymer-based disposable hemostats
    • Integration of nanotechnology to create more efficient and targeted hemostats
  • Market Challenges
    • Risk of infection and cross contamination associated with the use of hemostats tools and reagents

Porter's Five Forces: A Strategic Tool for Navigating the Hemostats Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hemostats Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hemostats Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hemostats Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hemostats Market

A detailed market share analysis in the Hemostats Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hemostats Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hemostats Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hemostats Market

A strategic analysis of the Hemostats Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hemostats Market, highlighting leading vendors and their innovative profiles. These include A.R. Medicom, Inc., ACTEON Group, Advamedica Inc., Advanced Medical Solutions Group PLC, Advin Health Care, Aegis Lifesciences Private Limited, Argon Medical Devices, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Betatech Medical, Convatec Group PLC, Cook Group Incorporated, Cortis Medtech Pvt Ltd, Cotran Corporation, Dolphin Sutures by Futura Surgicare Pvt. Ltd., Dynarex Corporation, Gelita AG, Hangzhou Singclean Medical Products Co.,Ltd., Healthium Medtech Ltd, Hemostasis, LLC, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Medcura, Inc., Medline Industries, LP, Medprin Biotech GmbH, Medtronic PLC, Meril Life Sciences Pvt. Ltd., Olympus Corporation, Pfizer Inc., Rousselot BV by Darling Ingredients International Holding B.V., Royal DSM, Shilpa Medicare Limited, Stapleline Medizintechnik GmbH, Stryker Corporation, SYMATESE, Teleflex Incorporated, Terumo Corporation, Zhejiang Perfectseal New Material Technology Co., Ltd., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Hemostats Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, and Thrombin-Based Hemostats.
  • Based on Formulation, market is studied across Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats, and Sponge Hemostats.
  • Based on Application, market is studied across Cardiovascular Surgery, General Surgery, Gynecological Surgery, Neurological Surgery, Orthopedic Surgery, and Reconstructive Surgery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic disorders with increasing need for surgical interventions
      • 5.1.1.2. Growing inclination toward minimally invasive surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Rising incidences of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise of biopolymer-based disposable hemostats
      • 5.1.3.2. Integration of nanotechnology to create more efficient and targeted hemostats
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of infection and cross contamination associated with the use of hemostats tools and reagents
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Expanding the use of combination hemostats owing to their enhanced effectiveness in minimizing bleeding
    • 5.2.2. Formulation: Growing potential of powder hemostats for controlling and preventing bleeding during surgical intervention
    • 5.2.3. Application: Significant role of hemostats in cardiovascular surgeries to prevent blood loss and ensure successful outcomes
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Hemostats Market, by Type

  • 6.1. Introduction
  • 6.2. Collagen-Based Hemostats
  • 6.3. Combination Hemostats
  • 6.4. Gelatin-Based Hemostats
  • 6.5. Oxidized Regenerated Cellulose-Based Hemostats
  • 6.6. Thrombin-Based Hemostats

7. Hemostats Market, by Formulation

  • 7.1. Introduction
  • 7.2. Matrix & Gel Hemostats
  • 7.3. Powder Hemostats
  • 7.4. Sheet & Pad Hemostats
  • 7.5. Sponge Hemostats

8. Hemostats Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Surgery
  • 8.3. General Surgery
  • 8.4. Gynecological Surgery
  • 8.5. Neurological Surgery
  • 8.6. Orthopedic Surgery
  • 8.7. Reconstructive Surgery

9. Americas Hemostats Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hemostats Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Hemostats Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures
    • 12.3.2. Baxter Launches PERCLOT Absorbable Hemostatic Powder
    • 12.3.3. Artivion Gains FDA Approval for PerClot, Starts Transfer to Baxter
    • 12.3.4. Olympus Europa SE & Co. KG Expands Endoclot Partnership with Endoclot to Launch Hemostatic Agents
    • 12.3.5. Darling Ingredients Completes Acquisition of Brazilian Gelatin and Collagen Producer Gelnex
    • 12.3.6. Chitosan-Based Hemostat For Controlling Severe Surgical Bleeding Gets FDA Clearance
    • 12.3.7. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
    • 12.3.8. Medcura, Inc. Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
    • 12.3.9. Medtronic plc Nexpowder Endoscopic Hemostasis System Receives U.S. FDA Clearance
    • 12.3.10. Hemostasis LLC Closes Acquisition of Fiagon Medical Technologies
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. A.R. Medicom, Inc.
  • 2. ACTEON Group
  • 3. Advamedica Inc.
  • 4. Advanced Medical Solutions Group PLC
  • 5. Advin Health Care
  • 6. Aegis Lifesciences Private Limited
  • 7. Argon Medical Devices
  • 8. B. Braun SE
  • 9. Baxter International Inc.
  • 10. Becton, Dickinson and Company
  • 11. Betatech Medical
  • 12. Convatec Group PLC
  • 13. Cook Group Incorporated
  • 14. Cortis Medtech Pvt Ltd
  • 15. Cotran Corporation
  • 16. Dolphin Sutures by Futura Surgicare Pvt. Ltd.
  • 17. Dynarex Corporation
  • 18. Gelita AG
  • 19. Hangzhou Singclean Medical Products Co.,Ltd.
  • 20. Healthium Medtech Ltd
  • 21. Hemostasis, LLC
  • 22. Integra LifeSciences Holdings Corporation
  • 23. Johnson & Johnson Services, Inc.
  • 24. Medcura, Inc.
  • 25. Medline Industries, LP
  • 26. Medprin Biotech GmbH
  • 27. Medtronic PLC
  • 28. Meril Life Sciences Pvt. Ltd.
  • 29. Olympus Corporation
  • 30. Pfizer Inc.
  • 31. Rousselot BV by Darling Ingredients International Holding B.V.
  • 32. Royal DSM
  • 33. Shilpa Medicare Limited
  • 34. Stapleline Medizintechnik GmbH
  • 35. Stryker Corporation
  • 36. SYMATESE
  • 37. Teleflex Incorporated
  • 38. Terumo Corporation
  • 39. Zhejiang Perfectseal New Material Technology Co., Ltd.
  • 40. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. HEMOSTATS MARKET RESEARCH PROCESS
  • FIGURE 2. HEMOSTATS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEMOSTATS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEMOSTATS MARKET DYNAMICS
  • TABLE 7. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEMOSTATS MARKET SIZE, BY COLLAGEN-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEMOSTATS MARKET SIZE, BY COMBINATION HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEMOSTATS MARKET SIZE, BY GELATIN-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEMOSTATS MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEMOSTATS MARKET SIZE, BY THROMBIN-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEMOSTATS MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEMOSTATS MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HEMOSTATS MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEMOSTATS MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HEMOSTATS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEMOSTATS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HEMOSTATS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023